Découvrez ce que disent vraiment les chiffres — avant le marché
Analyser maintenant
Sentiment des actualités
Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?
Analyser maintenant
Acheter / Conserver / Vendre
Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.
Analyser maintenant
Évaluation des risques
Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.
Analyser maintenant
Juste valeur
Cette action est-elle bon marché, correctement valorisée ou surévaluée ?
Analyser maintenant
Dernières analyses d’IA sur TELO GENOMICS CORP
Pas de cours
Cours de clôture XTSX 28.04.2026:
0,05 CAD
28.04.2026 20:00
Cours actuels de TELO GENOMICS CORP
Bourse
Ticker
Devise
Dernier échange
Cours
Variation journalière
UTC
TDSGF
USD
28.04.2026 20:00
0,04 USD
0,00 USD
TSX-V
TELO.V
CAD
28.04.2026 17:57
0,05 CAD
0,00 CAD
Flottant et Liquidité des Actions
Flottant Libre95,93 %
Actions en Flottant96,35 M
Actions en Circulation100,43 M
Profil de l'entreprise pour TELO GENOMICS CORP Action
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.
